Notice Concerning Transfer of Medical Equipment Business

Release Date: 2025/09/02

JEOL Ltd.（President & CEO: Izumi Oi）announces that at the Board of Directors meeting held on September 2, 2025, it resolved to transfer its medical equipment business to its newly-established wholly-owned subsidiary(Representative Director: Kiyotaka Fujino, “New Company”) through a company split (simplified absorption-type company split) and will transfer all shares of the New Company to SYSMEX CORPORATION (President: Kaoru Asano, “Sysmex”), and concluded a share transfer agreement with Sysmex on the same day.

The Share Transfer is scheduled to be executed on April 1, 2026.

Since the release of our first automated clinical chemistry analyzer in 1972, our medical equipment business has contributed to the development of medical care and maintenance of the people’s health by developing products and solutions that meet market needs. In particular, our automated clinical chemistry analyzers have received high praise from our customers because they have achieved the reduction of the required sample volume and reagent volume at the world’s top level of high throughput along with a unique method of diluting collected samples.

Sysmex is one of Japan's leading medical equipment manufacturers, and has a wealth of experience and an excellent track record in the field of clinical testing (specimen testing) over many years. Sysmex has also built a strong global network and has high brand power in the industry. In addition, since Sysmex has a clear growth strategy for this field and sufficient management resources, we believe that the realization of the absorption-type company split and the share transfer will demonstrate significant synergies in terms of R&D, production, and business development of automated clinical chemistry analyzers. The New Company will aim to further expand market opportunities by utilizing Sysmex's broad medical equipment product portfolio and combining the strengths of both companies.

For details, please refer to the following timely disclosure document.

Link

Notice Concerning the Establishment of a Subsidiary in the Medical Equipment Business Area, Absorption-type Company Split Between the Company and the Subsidiary(Simplified Absorption-type Company Split), and Transfer of Shares of the Subsidiary (PDF)